Reduce reproductive healthcare costs

To keep reproductive health care services and medications affordable, Alliance Governors have shared practical strategies to increase Medicaid reimbursement rates, bundle billing codes, and enact other novel affordability and workforce expansion measures.
Amicus Brief in Food and Drug Administration, et al., v. Alliance for Hippocratic Medicine
July 22, 2024

Amicus Brief in Food and Drug Administration, et al., v. Alliance for Hippocratic Medicine

Governor Kotek and 21 other governors filed an amicus brief with the U.S. Supreme Court in support of abortion rights in Food and Drug Administration, et al., v. Alliance for Hippocratic Medicine. In this brief, the Reproductive Freedom Alliance governors argued that if the Court reverses FDA approval of Mifepristone and limits access to the vital medicine, it could undermine Governors’ ability to provide adequate healthcare services and would have far-reaching implications beyond reproductive healthcare.
Lawsuit Over Unnecessary Abortion Medication Restrictions
July 22, 2024

Lawsuit Over Unnecessary Abortion Medication Restrictions

As the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration lawsuit was underway, Oregon’s Attorney General Ellen Rosenblum joined Washington State’s Attorney General Bob Ferguson in co-leading a multi-state lawsuit against the FDA to protect enhanced access to mifepristone. The outcome of this lawsuit was Judge Thomas Rice’s decision barring the FDA from making any changes that could reduce the availability of mifepristone in the 17 states that signed on to the lawsuit.
Mifepristone Stockpile
July 22, 2024

Mifepristone Stockpile

In response to the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration’s lawsuit challenging the FDA’s approval of the medication abortion drug mifepristone, Oregon secured a three-year supply of the drug. This stockpile ensures that patients seeking abortion services in Oregon will continue to have access to a safe and effective method of abortion. Oregon also developed a plan to distribute its supply of mifepristone equitably to eligible prescribers.
Reproductive Health Policy Workgroup
July 22, 2024

Reproductive Health Policy Workgroup

The Oregon Health Authority (OHA) established a Reproductive Health Policy Workgroup to provide a coordinated, equity-centered, and comprehensive approach to advancing reproductive health goals in Oregon. Composed of representatives from a diverse set of programs and divisions within the agency, as well as agencies whose work impacts reproductive health, the workgroup provided input and coordinated on efforts related to reproductive health and autonomy from a holistic and intersectional perspective.
Oregon Health Authority’s Reproductive Health Program
July 22, 2024

Oregon Health Authority’s Reproductive Health Program

The Oregon Health Authority’s Reproductive Health Program has leveraged diverse funding streams to create more efficient and flexible funding sources for Oregon’s network of publicly funded reproductive health clinics, including new infrastructure grants using Title X funds to bolster access to reproductive health services.
Reproductive Health Infrastructure Investments
July 22, 2024

Reproductive Health Infrastructure Investments

Oregon allocated $3.4 million dollars to the Oregon Health Authority (OHA) as part of Public Health Modernization to support reproductive health infrastructure development. This funding created a state-wide abortion access website, provided OHA-wide reproductive health services reimbursement rate revisions and alignment, and provided infrastructure grants to service providers across the state.
The Reproductive Health and Access to Care Act
July 22, 2024

The Reproductive Health and Access to Care Act

This comprehensive public law expands access to reproductive health and gender-affirming care and establishes protections for those seeking and those providing this care by codifying abortion rights, protecting providers and patients, and expanding access to reproductive health care.
Amicus Brief in Food and Drug Administration, et al., v. Alliance for Hippocratic Medicine
July 22, 2024

Amicus Brief in Food and Drug Administration, et al., v. Alliance for Hippocratic Medicine

Governor Hochul and 21 other governors filed an amicus brief with the U.S. Supreme Court in support of abortion rights in Food and Drug Administration, et al., v. Alliance for Hippocratic Medicine. In this brief, the Reproductive Freedom Alliance governors argued that if the Court reverses FDA approval of Mifepristone and limits access to the vital medicine, it could undermine Governors’ ability to provide adequate healthcare services and would have far-reaching implications beyond reproductive healthcare.
Department of Health Guidance
July 22, 2024

Department of Health Guidance

The New York Department of Health finalized regulations to ensure that abortion law in New York is aligned with clinical standards, provides a safe and non-stigmatizing experience for patients, and that providers can offer abortion telehealth services without unnecessary barriers.
Fiscal Year 2023 Budget
July 22, 2024

Fiscal Year 2023 Budget

In the Fiscal Year 2023 Budget, Governor Hochul enshrined into law a requirement that health plans in New York must cover abortion services, without cost-sharing. The 2023 Budget also expanded the Family Planning Grant Program, maintaining state funding for
reproductive health services as New York reenters the federal Title X program, and included measures to reduce racial disparities in maternal mortality and
morbidity.